Jacobs Levy Equity Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,621
| Closed | -$528K | – | 939 |
|
|
2022
Q3 | $528K | Sell |
55,621
-3,144
| -5% | -$29.8K | ﹤0.01% | 822 |
|
|
2022
Q2 | $705K | Sell |
58,765
-84,260
| -59% | -$1.01M | 0.01% | 811 |
|
|
2022
Q1 | $1.87M | Buy |
143,025
+41,250
| +41% | +$540K | 0.01% | 635 |
|
|
2021
Q4 | $1.79M | Buy |
101,775
+87,815
| +629% | +$1.55M | 0.01% | 642 |
|
|
2021
Q3 | $303K | Buy |
+13,960
| New | +$303K | ﹤0.01% | 935 |
|
|
2020
Q4 | – | Sell |
-9,654
| Closed | -$994K | – | 1007 |
|
|
2020
Q3 | $994K | Sell |
9,654
-1,015
| -10% | -$105K | 0.01% | 666 |
|
|
2020
Q2 | $2.23M | Sell |
10,669
-2,561
| -19% | -$535K | 0.02% | 514 |
|
|
2020
Q1 | $1.29M | Buy |
13,230
+786
| +6% | +$76.8K | 0.02% | 573 |
|
|
2019
Q4 | $1.43M | Buy |
12,444
+7,144
| +135% | +$823K | 0.01% | 612 |
|
|
2019
Q3 | $289K | Buy |
5,300
+2,120
| +67% | +$116K | ﹤0.01% | 782 |
|
|
2019
Q2 | $378K | Sell |
3,180
-1,180
| -27% | -$140K | 0.01% | 784 |
|
|
2019
Q1 | $228K | Sell |
4,360
-5,573
| -56% | -$291K | ﹤0.01% | 877 |
|
|
2018
Q4 | $313K | Buy |
9,933
+3,904
| +65% | +$123K | 0.01% | 806 |
|
|
2018
Q3 | $365K | Sell |
6,029
-2,246
| -27% | -$136K | 0.01% | 835 |
|
|
2018
Q2 | $439K | Buy |
8,275
+1,286
| +18% | +$68.2K | 0.01% | 825 |
|
|
2018
Q1 | $405K | Sell |
6,989
-1,870
| -21% | -$108K | 0.01% | 812 |
|
|
2017
Q4 | $310K | Sell |
8,859
-310
| -3% | -$10.8K | 0.01% | 844 |
|
|
2017
Q3 | $335K | Buy |
9,169
+970
| +12% | +$35.4K | 0.01% | 770 |
|
|
2017
Q2 | $205K | Buy |
8,199
+5,754
| +235% | +$144K | ﹤0.01% | 834 |
|
|
2017
Q1 | $66K | Buy |
+2,445
| New | +$66K | ﹤0.01% | 883 |
|
|
2016
Q2 | – | Sell |
-2,740
| Closed | -$142K | – | 1145 |
|
|
2016
Q1 | $142K | Buy |
+2,740
| New | +$142K | ﹤0.01% | 1008 |
|